Navigation Links
WuXi PharmaTech Named a Top Ten Outsourcing Enterprise in China for Five Consecutive Years

SHANGHAI, June 28, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, announced that it has been selected as one of the Top Ten Outsourcing Enterprise in China for 2012 by China's Ministry of Commerce (MOC). The list was announced at China's Fifth Annual International Service Outsourcing Cooperation Conference, held in Nanjing on June 20, 2012. WuXi PharmaTech is the only life science R&D service company among the top ten outsourcing enterprises.

Because of its creative business model of serving life science R&D industry and contribution to China's life science industry, WuXi PharmaTech has been selected into the Top 10 list for five consecutive years since the selection was initiated in 2008 by MOC. Earlier in 2011, Dr. Ge Li, Chairman and CEO, was named a Top Ten Contributor to China's Outsourcing Industry.

"We are honored to be consistently recognized as a top outsourcing company in China," Dr. Li said. "This speaks volume for WuXi's service business model. As a leading life science R&D service company, we will strive to improve our capabilities and capacities to better serve our pharmaceutical, biotechnology and medical device customers and partners, to help bring new products into market sooner and more cost effectively to benefit patients in needs."

Issued annually by Council for International Investment Promotion (CCIIP), a non-profit organization under Ministry of Commerce, the Top Ten Outsourcing Chinese Enterprise List recognizes the best outsourcing enterprises in China that have achieved great business growth on a yearly basis.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit or contact:

Aaron Shi (for the media)
Tel:   +86-21-5046-4362

Ronald Aldridge (for investors)
Tel:   +1-201-585-2048

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Announces Third-Quarter 2011 Results
2. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
3. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
4. Sequenom Named to NASDAQ Global Select Market
5. U of Toronto experiment named top breakthrough of 2011 by Physics World
6. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
7. Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine
8. Royals Batter Billy Butler Named Hutch Award Winner
9. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
10. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
11. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
Post Your Comments:
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: ) ... customers enhanced security to access and transact across ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):